Health and Biosecurity Flagship, The Australian eHealth Research Centre, Melbourne, Victoria, Australia.
Department of Molecular Imaging & Therapy, Austin Health, LVL1 Harrold STOKES Block, 145 Studley Road, Heidelberg, Melbourne, Victoria, 3084, Australia.
Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2225-2232. doi: 10.1007/s00259-021-05191-9. Epub 2021 Jan 26.
Previous studies have shown that Aβ-amyloid (Aβ) likely promotes tau to spread beyond the medial temporal lobe. However, the Aβ levels necessary for tau to spread in the neocortex is still unclear.
Four hundred sixty-six participants underwent tau imaging with [18F]MK6420 and Aβ imaging with [F]NAV4694. Aβ scans were quantified on the Centiloid (CL) scale with a cut-off of 25 CL for abnormal levels of Aβ (A+). Tau scans were quantified in three regions of interest (ROI) (mesial temporal (Me); temporoparietal neocortex (Te); and rest of neocortex (R)) and four mesial temporal region (entorhinal cortex, amygdala, hippocampus, and parahippocampus). Regional tau thresholds were established as the 95%ile of the cognitively unimpaired A- subjects. The prevalence of abnormal tau levels (T+) along the Centiloid continuum was determined.
The plots of prevalence of T+ show earlier and greater increase along the Centiloid continuum in the medial temporal area compared to neocortex. Prevalence of T+ was low but associated with Aβ level between 10 and 40 CL reaching 23% in Me, 15% in Te, and 11% in R. Between 40 and 70 CL, the prevalence of T+ subjects per CL increased fourfold faster and at 70 CL was 64% in Me, 51% in Te, and 37% in R. In cognitively unimpaired, there were no T+ in R below 50 CL. The highest prevalence of T+ were found in the entorhinal cortex, reaching 40% at 40 CL and 80% at 60 CL.
Outside the entorhinal cortex, abnormal levels of cortical tau on PET are rarely found with Aβ below 40 CL. Above 40 CL prevalence of T+ accelerates in all areas. Moderate Aβ levels are required before abnormal neocortical tau becomes detectable.
先前的研究表明,Aβ-淀粉样蛋白(Aβ)可能促进 tau 蛋白在海马体以外的区域传播。然而,tau 蛋白在大脑新皮层传播所需的 Aβ 水平仍不清楚。
466 名参与者接受了[18F]MK6420 的 tau 成像和[F]NAV4694 的 Aβ 成像。Aβ 扫描采用 Centiloid(CL)量表进行量化,截断值为 25 CL,用于异常 Aβ(A+)水平。tau 扫描在三个感兴趣区域(ROI)(内侧颞叶(Me);颞顶叶新皮层(Te);和其余新皮层(R))和四个内侧颞叶区域(内嗅皮层、杏仁核、海马体和海马旁回)进行量化。区域性 tau 阈值被确定为认知正常的 A-受试者的 95%ile。沿着 Centiloid 连续统确定异常 tau 水平(T+)的患病率。
T+患病率的图显示,在内侧颞叶区域,与新皮层相比,tau 水平在 Centiloid 连续统上更早且更大幅度地增加。T+的患病率较低,但与 Aβ 水平在 10 到 40 CL 之间相关,Me 中达到 23%,Te 中达到 15%,R 中达到 11%。在 40 到 70 CL 之间,每 CL 的 T+受试者的患病率增加了四倍,在 70 CL 时,Me 中为 64%,Te 中为 51%,R 中为 37%。在认知正常的人群中,R 区低于 50 CL 时没有 T+。在 entorhinal 皮层中发现了最高的 T+患病率,在 40 CL 时达到 40%,在 60 CL 时达到 80%。
在 Aβ 低于 40 CL 时,外侧颞叶以外的大脑皮层 tau 水平异常很少见。在 40 CL 以上,所有区域的 T+ 患病率都加速增加。在异常的新皮层 tau 变得可检测之前,需要有中等水平的 Aβ。